Omega-3 supplementation not associated with increased bleeding risk

Cardiovascular disease has remained the leading cause of mortality for over three decades, accounting for approximately one-third of global deaths annually.¹ More than four out of five cardiovascular disease-related deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.²

Omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been clearly identified as a promising natural therapy for supporting cardiovascular health, with various studies indicating an association with cardiovascular risk reduction,³ reduced cardiovascular mortality,⁴ and improved cardiovascular outcomes.⁴